TAO Synergies Inc. (TAOX)
NASDAQ: TAOX
· Real-Time Price · USD
5.85
0.38 (6.95%)
At close: Sep 26, 2025, 3:59 PM
5.90
0.85%
After-hours: Sep 26, 2025, 07:33 PM EDT
Company Description
Clinical-stage biopharmaceutical company developing a bryostatin‑1 platform for Alzheimer’s and other neurodegenerative/cognitive diseases.
Also pivoting to a digital-asset treasury strategy focused on acquiring and staking TAO cryptocurrency.
TAO Synergies Inc.
| Country | United States |
| IPO Date | Jul 2, 2025 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 4 |
| CEO | Joshua N. Silverman |
Contact Details
Address: 1185 Avenue of the Americas, 3rd Floor New York, United States | |
| Website | https://www.synaptogen.com |
Stock Details
| Ticker Symbol | TAOX |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | n/a |
| CUSIP Number | n/a |
| ISIN Number | US87167T3005 |
| Employer ID | - |
| SIC Code | n/a |